According to a new market research report published by Global Market Estimates, the Global Cell & Gene Therapy Raw Material Testing Market is projected to grow from USD 13.1 billion in 2022 to USD 21.3 billion in 2027 at a CAGR of 17.3% from 2022 to 2027.
Thermo Fisher Scientific, Merck KGaA, Catalent Inc., Charles River, Pace Analytical Life Sciences, Agilent Technologies, Intertek Group PLC, Element Material Technology, and Eurofins Scientific, among others, are some key players in the cell & gene therapy raw material testing market.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on “Global Cell & Gene Therapy Raw Material Testing Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/cell-gene-therapy-raw-material-testing-market-3867
By Type Scope (Cell Therapy, Gene Therapy), By Service Scope (Sterility Testing, Mycoplasma Detection Assays, Endotoxin Detection, Bioburden Testing, Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis
Service
Scope Outlook (Revenue, USD Billion, 2022-2027)
·
Sterility Testing
·
Mycoplasma Detection Assays
·
Endotoxin Detection
·
Bioburden Testing
·
Others
Type Scope Outlook (Revenue, USD Billion, 2022-2027)
·
Cell Therapy
·
Gene Therapy
Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
Europe
Asia Pacific
Central & South America
Middle East & Africa
Contact:
Yash Jain
Email
address: yash.jain@globalmarketestimates.com
Phone
Number: +1 6026667238